𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Hepatitis C virus infection in patients with B-cell lymphoproliferative disorders

✍ Scribed by Guida, M; D’Elia, G; Benvestito, S; Casamassima, A; Micelli, G; Quaranta, M; Moschetta, R; De Lena, M; Lorusso, V

Book ID
110055184
Publisher
Nature Publishing Group
Year
2002
Tongue
English
Weight
81 KB
Volume
16
Category
Article
ISSN
0887-6924

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High prevalence of hepatitis C virus inf
High prevalence of hepatitis C virus infection in patients with B-cell lymphoproliferative disorders in Italy
✍ De Rosa, Gennaro; Gobbo, Maria Luisa; De Renzo, Amalia; Notaro, Rosario; Garofal 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 46 KB 👁 2 views

Starting from the observation that a number of consecutive patients with non-Hodgkin's lymphoma (NHL) resulted positive for hepatitis C virus (HCV) antibodies on routine testing, we set up a survey for HCV contact prevalence in all patients with lymphoproliferative disorders (LPD) followed in our in

Infection of B cells with hepatitis C vi
Infection of B cells with hepatitis C virus for the development of lymphoproliferative disorders in patients with chronic hepatitis C
✍ Momoko Inokuchi; Takayoshi Ito; Manabu Uchikoshi; Yuu Shimozuma; Kenichi Morikaw 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 214 KB 👁 1 views

## Abstract Infection with hepatitis C virus (HCV) is associated with lymphoproliferative disorders, represented by essential mixed cryoglobulinemia and B‐cell non‐Hodgkin's lymphoma, but the pathogenic mechanism remains obscure. HCV may infect B cells or interact with their cell surface receptors,

Hepatitis C virus infection and lymphopr
Hepatitis C virus infection and lymphoproliferative disorders after liver transplantation
✍ Nizar N. Zein; Rogelio G. Perez; Russel H. Wiesner 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 34 KB 👁 2 views

with treatment failures moving on to combination therapy (IFN/CMB). The primary difference between the two best strategies (IFN/CBM vs. CMB-G) was that the CMB-G strategy was more successful with those with genotype 1. Thus, the genotyping strategy reached more people with less responsive disease th